Zobrazeno 1 - 10
of 45
pro vyhledávání: '"Alexandra, Voutsina"'
Autor:
Alexios Matikas, Alexandra Voutsina, Eleni Lagoudaki, Dora Hatzidaki, Maria Trypaki, Giannis Stoupis, Maria Tzardi, Dimitrios Mavroudis, Vasilios Georgoulias
Publikováno v:
Translational Oncology, Vol 10, Iss 4, Pp 693-698 (2017)
INTRODUCTION: The presence of KRAS mutations in patients with metastatic colorectal cancer (mCRC) predicts poor response to agents targeting the EGFR. Even in patients with RAS wild type (WT) tumors, resistance eventually develops due to multiple mec
Externí odkaz:
https://doaj.org/article/bc5bf3bebde74ec7bcaab825cdee7cf3
Autor:
Evi Lianidou, Vassilis Georgoulias, Amanda Psyrri, Alexandra Voutsina, Eleni Politaki, Maria Chimonidou, Eleni Tzanikou, Areti Strati, Sophia Mastoraki
Supplementary Figure 1A Supplementary Figure 1B Supplementary Figure 2A Supplementary Figure 2B
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aac4f5877bac632e8f5bf1e396fa6151
https://doi.org/10.1158/1078-0432.22460181.v1
https://doi.org/10.1158/1078-0432.22460181.v1
Autor:
Evi Lianidou, Vassilis Georgoulias, Amanda Psyrri, Alexandra Voutsina, Eleni Politaki, Maria Chimonidou, Eleni Tzanikou, Areti Strati, Sophia Mastoraki
Purpose: Liquid biopsy provides real-time monitoring of tumor evolution and response to therapy through analysis of circulating tumor cells (CTCs) and plasma-circulating tumor DNA (ctDNA). ESR1 epigenetic silencing potentially affects response to end
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::29cfba7eeafd391429bbb1b71b34f35f
https://doi.org/10.1158/1078-0432.c.6524418.v1
https://doi.org/10.1158/1078-0432.c.6524418.v1
Autor:
Ippokratis Messaritakis, Maria Stogiannitsi, Asimina Koulouridi, Maria Sfakianaki, Alexandra Voutsina, Afroditi Sotiriou, Elias Athanasakis, Evangelos Xynos, Dimitris Mavroudis, Maria Tzardi, John Souglakos
Publikováno v:
PLoS ONE, Vol 13, Iss 6, p e0197327 (2018)
BACKGROUND:Toll-like receptors (TLRs) play essential role in innate and acquired immunity, are expressed in various cell types, and are associated with altered susceptibility to many diseases, and cancers. The aim of this study was to investigate TLR
Externí odkaz:
https://doaj.org/article/bd877238f2874b42aeb6bc4dd593db47
Autor:
Asimina, Koulouridi, Michaela, Karagianni, Ippokratis, Messaritakis, Maria, Sfakianaki, Alexandra, Voutsina, Maria, Trypaki, Maria, Bachlitzanaki, Evangelos, Koustas, Michalis V, Karamouzis, Anastasios, Ntavatzikos, Anna, Koumarianou, Nikolaos, Androulakis, Dimitrios, Mavroudis, Maria, Tzardi, John, Souglakos
Publikováno v:
Cancers. 14(14)
Colorectal cancer (CRC) remains a major public health issue. The detection of parameters that affect CRC prognosis is of great significance.
Publikováno v:
Current Genetics. 65:799-816
To gain insights on the transcriptional switches that modulate proper copper homeostasis in yeast, we have examined in detail functional interactions of the relevant transcriptional activator Mac1. We identified Hir1 transcriptional repressor and his
Autor:
Aristea Kalikaki, Helen Politaki, John Souglakos, Stella Apostolaki, Elisavet Papadimitraki, Nefeli Georgoulia, Maria Tzardi, Dimitris Mavroudis, Vassilis Georgoulias, Alexandra Voutsina
Publikováno v:
PLoS ONE, Vol 9, Iss 8, p e104902 (2014)
Circulating tumor cells (CTCs) could represent a non-invasive source of cancer cells used for longitudinal monitoring of the tumoral mutation status throughout the course of the disease. The aims of the present study were to investigate the detection
Externí odkaz:
https://doaj.org/article/2d96b3b05de14b82abdce8a3dd4a2329
Autor:
Ioannis S. Pateras, Alexandra Voutsina, Margaritis Avgeris, Athina Markou, Konstantinos Vachlas, Konstantinos Potaris, Emmanouil Athanasiadis, Vassilis Georgoulias, Periklis Makrythanasis, Apostolos Klinakis, Eleni Patsea, Ioannis Vamvakaris, Athanasios Kotsakis, Evi Lianidou, Zoi Kanaki
Publikováno v:
Cancers
Volume 13
Issue 10
Cancers, Vol 13, Iss 2446, p 2446 (2021)
Volume 13
Issue 10
Cancers, Vol 13, Iss 2446, p 2446 (2021)
Simple Summary It is widely thought that tumors are composed of different subpopulations of cancer cells carrying genetic alterations with some of them being common among all cells while others are unique for each subpopulation. This variable genetic
Autor:
Zacharenia Saridaki, Maria Tzardi, Maria Sfakianaki, Chara Papadaki, Alexandra Voutsina, Aristea Kalykaki, Ippokratis Messaritakis, Kyriakos Mpananis, Dimitris Mavroudis, Efstathios Stathopoulos, Vassilis Georgoulias, John Souglakos
Publikováno v:
PLoS ONE, Vol 8, Iss 12, p e84604 (2013)
To prospectively evaluate the usefulness of the BRAFV600E mutation detection in daily clinical practice in patients with metastatic Colorectal Cancer (mCRC).504 mCRC patients treated with systemic chemotherapy ± biologics were analyzed.A statistical
Externí odkaz:
https://doaj.org/article/faf485e051214337b50157574e0a3a05
Autor:
Z. Saridaki, Evaghelos Xynos, John Souglakos, Nikolaos Gouvas, Aristea Kalykaki, Alexandra Voutsina, Maria Tzardi, Maria Sfakianaki, Telenia Kalambaliki, Ioannis Boukovinas, Athanasios Athanasiadis
Publikováno v:
Forum of Clinical Oncology, Vol 9, Iss 1, Pp 31-36 (2019)
Introduction Several studies show that mutational profiles could influence treatment decisions in patients with metastatic CRC (mCRC). KRAS mutational status was the first step in biomarkers development in the era of molecular targeted therapies. Rec